SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001144204-18-008759
Filing Date
2018-02-14
Accepted
2018-02-14 14:50:15
Documents
1
Group Members
ANTOINE PAPIERNIKDENIS LUCQUINMONIQUE SAULNIERSOFINNOVA PARTNERS SAS, A FRENCH CORP

Document Format Files

Seq Description Document Type Size
1 SC 13D/A tv486133_sc13da.htm SC 13D/A 71435
  Complete submission text file 0001144204-18-008759.txt   73036
Mailing Address TUBORG BOULEVARD 5 HELLERUP G7 DK-2900
Business Address TUBORG BOULEVARD 5 HELLERUP G7 DK-2900 45 36 94 44 86
Ascendis Pharma A/S (Subject) CIK: 0001612042 (see all company filings)

IRS No.: 000000000 | State of Incorp.: G7 | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-88586 | Film No.: 18611231
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1

Mailing Address IMMEUBLE LE CENTORIAL 16-18 RUE DU 4 SEPTEMBRE PARIS I0 75002
Business Address IMMEUBLE LE CENTORIAL 16-18 RUE DU 4 SEPTEMBRE PARIS I0 75002 0033 1 55 42 78 78
Sofinnova Capital V FCPR (Filed by) CIK: 0001649177 (see all company filings)

IRS No.: 000000000
Type: SC 13D/A